Recently, CD36 has been identified as a novel marker for macrophage activation in the context of metabolic stimuli such as free fatty acids (FFA) or hyperglycemia, rather than by bacterial infection-induced inflammation23, indicating a very unique subset of pro-inflammatory macrophages with a more specific role in processes such as atherogenesis. Here, CD36 is linked to Hyperglycemia.